Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related Genes

26 Apr 2022

Abstract excerpt

Background: Malignant rhabdoid tumor of the kidney (MRTK) is an infrequent malignant tumor in childhood, accounting for approximately 2% of all childhood kidney tumors. Although the development of current treatments, the overall survival (OS) rate of MRTK patients is only 25%. The aim of this research was to explore the prognostic value of genes associated with the mTORC1 signaling pathway in MRTK. Methods: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Chromatin Remodeling and Cancer
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35558559
DOI: 10.3389/fmolb.2022.843234

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related GenesPMID 35558559Read ↗

mTORC-Driven Immunogenomic Reprogramming Shapes Prognosis and Therapeutic Vulnerabilities in Unfavorable Histology Wilms TumorSemantic proximity Read ↗

Proteogenomic characterization of MiT family translocation renal cell carcinomaSemantic proximity Read ↗

Investigating the dysfunctional pathogenesis of Wilms’ tumor through a multidimensional integration strategySemantic proximity Read ↗

Kidney cancer pathology in the new context of targeted therapy.Semantic proximity Read ↗

Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumorSemantic proximity Read ↗

Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumorSemantic proximity Read ↗

Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancerSemantic proximity Read ↗

ZSTK474 Targeting PIK3R3 Inhibits the Wilms' Tumor through G0 / G1 Phase ArrestSemantic proximity Read ↗

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.Semantic proximity Read ↗

Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.Semantic proximity Read ↗

Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population.Semantic proximity Read ↗

A Risk Signature of Nine Autophagy-Related Genes Associated With Immune Microenvironment and Clinical Prognosis in Wilms TumorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.